CNSX:SPR

Spirit AeroSystems Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume199,545 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Spirit AeroSystems (CNSX:SPR) Vs. RIV, WLLW, LABS, KHRN, DN, and META

Should you be buying SPR stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to Spirit AeroSystems, including RIV Capital (RIV), Willow Biosciences Inc. (WLLW.TO) (WLLW), MediPharm Labs (LABS), Khiron Life Sciences (KHRN), Delta 9 Cannabis (DN), and Meta Growth (META).

RIV Capital (TSE:RIV) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for RIV Capital and Spirit AeroSystems, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
RIV Capital01002.00
Spirit AeroSystems0000N/A

RIV Capital currently has a consensus target price of C$4.00, indicating a potential upside of 107.25%.

Profitability

This table compares RIV Capital and Spirit AeroSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RIV CapitalN/AN/AN/A
Spirit AeroSystemsN/AN/AN/A

Earnings & Valuation

This table compares RIV Capital and Spirit AeroSystems' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RIV CapitalC$15.44 million17.49$-106,223,568.00C($0.76)-2.54
Spirit AeroSystemsN/AN/AN/AN/AN/A

Spirit AeroSystems has lower revenue, but higher earnings than RIV Capital.

Summary

RIV Capital beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.

Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Profitability

This table compares Willow Biosciences Inc. (WLLW.TO) and Spirit AeroSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Willow Biosciences Inc. (WLLW.TO)N/AN/AN/A
Spirit AeroSystemsN/AN/AN/A

Earnings and Valuation

This table compares Willow Biosciences Inc. (WLLW.TO) and Spirit AeroSystems' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Willow Biosciences Inc. (WLLW.TO)C$10,000.0015,531.77$-51,032,952.00C($0.41)-3.04
Spirit AeroSystemsN/AN/AN/AN/AN/A

Spirit AeroSystems has lower revenue, but higher earnings than Willow Biosciences Inc. (WLLW.TO).

Analyst Recommendations

This is a breakdown of recent recommendations for Willow Biosciences Inc. (WLLW.TO) and Spirit AeroSystems, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Willow Biosciences Inc. (WLLW.TO)0000N/A
Spirit AeroSystems0000N/A

Willow Biosciences Inc. (WLLW.TO) currently has a consensus price target of C$2.25, suggesting a potential upside of 78.57%.

Summary

Willow Biosciences Inc. (WLLW.TO) beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.

MediPharm Labs (TSE:LABS) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for MediPharm Labs and Spirit AeroSystems, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MediPharm Labs02023.00
Spirit AeroSystems0000N/A

MediPharm Labs presently has a consensus target price of C$1.53, suggesting a potential upside of 225.53%.

Profitability

This table compares MediPharm Labs and Spirit AeroSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MediPharm LabsN/AN/AN/A
Spirit AeroSystemsN/AN/AN/A

Earnings & Valuation

This table compares MediPharm Labs and Spirit AeroSystems' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$36.01 million3.37$-123,815,040.00C($0.48)-0.98
Spirit AeroSystemsN/AN/AN/AN/AN/A

Spirit AeroSystems has lower revenue, but higher earnings than MediPharm Labs.

Summary

MediPharm Labs beats Spirit AeroSystems on 2 of the 2 factors compared between the two stocks.

Khiron Life Sciences (CVE:KHRN) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.

Profitability

This table compares Khiron Life Sciences and Spirit AeroSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Khiron Life SciencesN/AN/AN/A
Spirit AeroSystemsN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Khiron Life Sciences and Spirit AeroSystems, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Khiron Life Sciences0000N/A
Spirit AeroSystems0000N/A

Khiron Life Sciences presently has a consensus price target of C$1.20, indicating a potential upside of 155.32%.

Earnings and Valuation

This table compares Khiron Life Sciences and Spirit AeroSystems' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Khiron Life SciencesC$8.01 million8.81$-39,493,921.00C($0.26)-1.79
Spirit AeroSystemsN/AN/AN/AN/AN/A

Spirit AeroSystems has lower revenue, but higher earnings than Khiron Life Sciences.

Summary

Khiron Life Sciences beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.

Delta 9 Cannabis (TSE:DN) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Valuation and Earnings

This table compares Delta 9 Cannabis and Spirit AeroSystems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$52.05 million1.12$-7,346,808.00C($0.07)-7.92
Spirit AeroSystemsN/AN/AN/AN/AN/A

Spirit AeroSystems has lower revenue, but higher earnings than Delta 9 Cannabis.

Profitability

This table compares Delta 9 Cannabis and Spirit AeroSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Delta 9 CannabisN/AN/AN/A
Spirit AeroSystemsN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Delta 9 Cannabis and Spirit AeroSystems, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Delta 9 Cannabis00014.00
Spirit AeroSystems0000N/A

Delta 9 Cannabis presently has a consensus target price of C$1.10, suggesting a potential upside of 92.98%.

Summary

Delta 9 Cannabis beats Spirit AeroSystems on 2 of the 2 factors compared between the two stocks.

Meta Growth (CVE:META) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings.

Earnings and Valuation

This table compares Meta Growth and Spirit AeroSystems' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthC$60.96 million0.54$-50,412,840.00C($0.21)-0.66
Spirit AeroSystemsN/AN/AN/AN/AN/A

Spirit AeroSystems has lower revenue, but higher earnings than Meta Growth.

Analyst Ratings

This is a summary of recent ratings and target prices for Meta Growth and Spirit AeroSystems, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth0000N/A
Spirit AeroSystems0000N/A

Profitability

This table compares Meta Growth and Spirit AeroSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
Spirit AeroSystemsN/AN/AN/A

Summary

Meta Growth beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.


Spirit AeroSystems Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RIV
RIV Capital
0.8$1.93flatC$270.11 millionC$15.44 million-2.54
WLLW
Willow Biosciences Inc. (WLLW.TO)
1.1$1.26flatC$155.32 millionC$10,000.00-3.04
LABS
MediPharm Labs
1.4$0.47flatC$121.24 millionC$36.01 million-0.98
KHRN
Khiron Life Sciences
0.9$0.47flatC$67.34 millionC$8.01 million-1.79
DN
Delta 9 Cannabis
1.4$0.57flatC$58.16 millionC$52.05 million-7.92
META
Meta Growth
0.8$0.14flatC$36.69 millionC$60.96 million-0.66Gap Up
NRTH
48North Cannabis
0.7$0.15flatC$36.44 millionC$17.36 million-0.55Gap Down
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
BAMM
28896
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
AGRA
Agraflora Organics International
1.4N/AN/A$0.00N/A0.00High Trading Volume
GRIN
Grindrod Shipping
1.7N/AN/A$0.00N/A0.00High Trading Volume
IMCC
IM Cannabis
0.0N/AN/A$0.00N/A0.00High Trading Volume
PULL
Mind Cure Health
1.7N/AN/A$0.00N/A0.00High Trading Volume
BUZZ
VanEck Vectors Social Sentiment ETF
1.0N/AN/A$0.00N/A0.00High Trading Volume
VIDA
Vidaroo
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.